Waiting
Login processing...

Trial ends in Request Full Access Tell Your Colleague About Jove
Journal / Cancer Research / Un targeting GPC3 bispecifico, GPC3-S-Fab, con…
JoVE Journal
Cancer Research

A subscription to JoVE is required to view this content.

JoVE Journal Cancer Research
Un targeting GPC3 bispecifico, GPC3-S-Fab, con potente citotossicità
Isolation and Characterization of Patient-derived Pancreatic Ductal Adenocarcinoma Organoid Models
Journal (Cancer Research)
Isolation and Characterization of Patient-derived Pancreatic Ductal Adenocarcinoma Organoid Models
Evaluating Cell Death Using Cell-Free Supernatant of Probiotics in Three-Dimensional Spheroid Cultures of Colorectal Cancer Cells
Journal (Cancer Research)
Evaluating Cell Death Using Cell-Free Supernatant of Probiotics in Three-Dimensional Spheroid Cultures of Colorectal Cancer Cells
 
Click here for the English version

Un targeting GPC3 bispecifico, GPC3-S-Fab, con potente citotossicità

Article DOI: 10.3791/57588-v • 11:13 min • July 12th, 2018
July 12th, 2018 •
1,2, 1,2, 1,2, 1,2, 1,2, 1,2, 1,2
1School of Pharmaceutical Sciences, Sun Yat-Sen University, 2Center for Cellular & Structural Biology, Sun Yat-Sen University

Chapters

Summary
Automatic Translation

Please note that all translations are automatically generated.

Click here for the English version.

Qui, presentiamo un protocollo per produrre un bispecifico GPC3-S-Fab in Escherichia coli. Purificata GPC3-S-Fab ha potente citotossicità contro le cellule di cancro del fegato positivo GPC3.

Tags

Ricerca sul cancro problema 137 anticorpo dell'anticorpo anticorpo singolo dominio inquinamenti GPC3-S-Fab GPC3 cancro del fegato
Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter